How Can Pharmaceutical Businesses Enter the Fertility Healthcare Market?
The increase in the number of infertility cases due to various factors such as delayed childbearing, sedentary lifestyle, and hormonal imbalance problems is making the healthcare sector consider Fertility health seriously. Fertility medicine gives couples who do not want to undergo surgical procedures for fertility treatments and are looking for minimally invasive fertility treatments. Adoreferm, a renowned gynecology medicine company in India , ensures it supplies its partners with WHO-cGMP certified products and helps them with brand visibility objectives with the help of marketing support. It also provides export services to Sri Lanka, Nigeria, Chile, and many more. Why enter the Fertility Healthcare Market? Fertility Drugs Market is estimated to be valued at approx USD 3 - 3.2 billion in 2026. Fertility Medicines emerge as pharmacological treatments and the major pharmacological classes include Gonadotropins, HCG trigger shots, GnRH agonists and steroid hormones. The reasons f...